184 related articles for article (PubMed ID: 28976288)
41. Dysregulated expression of the alternatively spliced variant mRNAs of the mu opioid receptor gene, OPRM1, in the medial prefrontal cortex of male human heroin abusers and heroin self-administering male rats.
Brown TG; Xu J; Hurd YL; Pan YX
J Neurosci Res; 2022 Jan; 100(1):35-47. PubMed ID: 32506472
[TBL] [Abstract][Full Text] [Related]
42. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ
J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442
[TBL] [Abstract][Full Text] [Related]
43. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.
Gao X; Wang Y; Lang M; Yuan L; Reece AS; Wang W
OMICS; 2017 Jul; 21(7):404-412. PubMed ID: 28692418
[TBL] [Abstract][Full Text] [Related]
44. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
45. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
Chawar C; Hillmer A; Lamri A; Kapczinski F; Thabane L; Pare G; Samaan Z
PLoS One; 2021; 16(12):e0261201. PubMed ID: 34910759
[TBL] [Abstract][Full Text] [Related]
46. Mu opioid receptor gene variants: lack of association with alcohol dependence.
Bergen AW; Kokoszka J; Peterson R; Long JC; Virkkunen M; Linnoila M; Goldman D
Mol Psychiatry; 1997; 2(6):490-4. PubMed ID: 9399694
[TBL] [Abstract][Full Text] [Related]
47. Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.
Zhang Y; Picetti R; Butelman ER; Ho A; Blendy JA; Kreek MJ
Neuropsychopharmacology; 2015 Mar; 40(5):1091-100. PubMed ID: 25336208
[TBL] [Abstract][Full Text] [Related]
48. The μ-opioid receptor gene polymorphism 118A>G weakens the pharmacological action of buprenorphine.
Imai H; Morita M; Morita H; Ohyama T; Tanaka S; Uchida S; Namiki N; Uemura N; Ohashi K
Int J Clin Pharmacol Ther; 2020 Nov; 58(11):626-633. PubMed ID: 32870152
[TBL] [Abstract][Full Text] [Related]
49. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population.
Zhang D; Shao C; Shao M; Yan P; Wang Y; Liu Y; Liu W; Lin T; Xie Y; Zhao Y; Lu D; Li Y; Jin L
Biol Psychiatry; 2007 Jun; 61(11):1244-51. PubMed ID: 17157823
[TBL] [Abstract][Full Text] [Related]
50. Mu Opioid Receptor Genetic Variation and Heroin Addiction.
Zubieta JK
Biol Psychiatry; 2015 Oct; 78(7):439-40. PubMed ID: 26360547
[No Abstract] [Full Text] [Related]
51. The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life.
Haupt LM; Haywood A; Sutherland HG; Yu C; Albury CL; Pharasi A; Zunk M; George R; Griffiths LR; Good P; Hardy J
Sci Rep; 2024 Feb; 14(1):3411. PubMed ID: 38341456
[TBL] [Abstract][Full Text] [Related]
52. Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.
Levran O; Peles E; Randesi M; Correa da Rosa J; Ott J; Rotrosen J; Adelson M; Kreek MJ
Pharmacogenomics; 2014 Dec; 15(16):2001-9. PubMed ID: 25521358
[TBL] [Abstract][Full Text] [Related]
53. Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
Lutz PE; Ayranci G; Chu-Sin-Chung P; Matifas A; Koebel P; Filliol D; Befort K; Ouagazzal AM; Kieffer BL
Neuropsychopharmacology; 2014 Oct; 39(11):2694-705. PubMed ID: 24874714
[TBL] [Abstract][Full Text] [Related]
54. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
[TBL] [Abstract][Full Text] [Related]
55. Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients.
De Capraris A; Cinnella G; Marolla A; Salatto P; Da Lima S; Vetuschi P; Consoletti L; Gesualdo L; Dambrosio M
Int J Immunopathol Pharmacol; 2011; 24(4):993-1004. PubMed ID: 22230405
[TBL] [Abstract][Full Text] [Related]
56. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.
Jones JD; Luba RR; Vogelman JL; Comer SD
Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286
[TBL] [Abstract][Full Text] [Related]
57. The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.
Klein G; Rossi GC; Waxman AR; Arout C; Juni A; Inturrisi CE; Kest B
Neurosci Lett; 2009 Jul; 457(3):115-9. PubMed ID: 19429175
[TBL] [Abstract][Full Text] [Related]
58. Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction.
Peles E; Levran O; Randesi M; Ott J; Kreek MJ; Adelson M
J Addict Med; 2019; 13(6):430-435. PubMed ID: 30844877
[TBL] [Abstract][Full Text] [Related]
59. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Brown MS; Paul J; Harvey-Wilkes K; Terrin N; Huggins GS; Aranda JV; Davis JM
JAMA; 2013 May; 309(17):1821-7. PubMed ID: 23632726
[TBL] [Abstract][Full Text] [Related]
60. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
